Outcome and Determinants of Outcome of COVID-19 Infection Among Hemodialysis Patients: Findings From a National Dialysis Network Program in India.
作者信息
Kakkanattu Tom Jose, Sankarasubbaiyan Suresh, Yadav Ashok K, Kundu Monica, Gowda Bg Mallikarjuna, Kumar Vivek, Shah Kamal, Jha Vivekanand
机构信息
Department of Nephrology, Postgraduate Institute of Medical Institute Education and Research, Chandigarh, India.
NephroPlus Dialysis Network, Hyderabad, India.
出版信息
Kidney Int Rep. 2021 May;6(5):1429-1432. doi: 10.1016/j.ekir.2021.03.003. Epub 2021 Mar 15.
Abstract
摘要
相似文献
1
Outcome and Determinants of Outcome of COVID-19 Infection Among Hemodialysis Patients: Findings From a National Dialysis Network Program in India.印度全国透析网络项目中血液透析患者新冠病毒感染的结局及结局的决定因素：研究结果
Kidney Int Rep. 2021 May;6(5):1429-1432. doi: 10.1016/j.ekir.2021.03.003. Epub 2021 Mar 15.
2
Management of COVID-19 in an Outpatient Dialysis Program.门诊透析项目中新冠病毒病的管理
Nephrol Nurs J. 2020 Sep-Oct;47(5):423-427.
3
Study of COVID-19 Pandemic in Representative Dialysis Population Across Mumbai, India: An Observational Multicentric Analysis.印度孟买代表性透析人群中新冠疫情的研究：一项观察性多中心分析
J Assoc Physicians India. 2020 Oct;68(10):13-17.
4
The emergency department care for hemodialysis patient during the COVID-19 pandemic.急诊科在 COVID-19 大流行期间对血液透析患者的护理。
Am J Emerg Med. 2021 Feb;40:47-54. doi: 10.1016/j.ajem.2020.12.006. Epub 2020 Dec 11.
5
[Reorganization of haemodialysis during COVID-19 emergency: a report from Dialysis Centers of Parma province].[新冠疫情紧急状态下血液透析的调整：帕尔马省透析中心的报告]
G Ital Nefrol. 2020 Oct 5;37(5):2020-vol5.
6
[The peak of the Coronavirus emergency and hemodialysis patients: the experience of the Dialysis Center in Crema].[新型冠状病毒紧急情况高峰期与血液透析患者：克雷马透析中心的经验]
G Ital Nefrol. 2020 Oct 5;37(5):2020-vol5.
7
Role of Screening for COVID-19 in Hemodialysis Wards, Results of a Single Center Study.血液透析病房中新冠病毒病筛查的作用：一项单中心研究结果
Iran J Kidney Dis. 2020 Sep;14(5):389-398.
8
Short daily and nocturnal hemodialysis: new therapies for a new century?每日短时和夜间血液透析：新世纪的新疗法？
Saudi J Kidney Dis Transpl. 2009 Jan;20(1):1-11.
9
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.大量 COVID-19 住院血液透析患者死亡的决定因素。
BMC Nephrol. 2021 Jan 14;22(1):29. doi: 10.1186/s12882-021-02233-0.
10
The clinical characteristics and course of COVID-19 in hemodialysis patients.血液透析患者中新型冠状病毒肺炎的临床特征及病程
Hemodial Int. 2020 Oct;24(4):534-540. doi: 10.1111/hdi.12861. Epub 2020 Aug 2.
引用本文的文献
1
Poor Outcome after Hospital Discharge in Patients with ESKD and COVID-19.终末期肾病（ESKD）合并新型冠状病毒肺炎（COVID-19）患者出院后预后不良
Indian J Nephrol. 2023 Mar-Apr;33(2):150-151. doi: 10.4103/ijn.ijn_286_21. Epub 2023 Feb 20.
2
High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort.高血浆成纤维细胞生长因子 23 水平与血液透析终末期肾病患者 COVID-19 风险增加相关：一项前瞻性队列研究结果。
Toxins (Basel). 2023 Jan 19;15(2):97. doi: 10.3390/toxins15020097.
3
COVID-19: A nephrologists' perspective.COVID-19：肾脏科医生的观点。
J Postgrad Med. 2022 Oct-Dec;68(4):187-193. doi: 10.4103/jpgm.jpgm_470_22.
4
Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients.2019冠状病毒病疫苗接种对血液透析患者的临床疗效
Kidney Int Rep. 2022 Oct;7(10):2176-2185. doi: 10.1016/j.ekir.2022.07.007. Epub 2022 Jul 16.
5
Mortality and risk factors for COVID-19 in hemodialysis patients: A systematic review and meta-analysis.血液透析患者中新冠病毒疾病的死亡率及风险因素：一项系统评价与荟萃分析
Sci Prog. 2022 Jul-Sep;105(3):368504221110858. doi: 10.1177/00368504221110858.
6
Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.印度一家三级医疗中心对感染和未感染新冠病毒的肾移植受者接种疫苗后抗刺突抗体反应的分析。
Clin Kidney J. 2022 Mar 3;15(7):1312-1321. doi: 10.1093/ckj/sfac057. eCollection 2022 Jul.
7
A Comprehensive Comparison of Clinical Presentation and Outcomes of Kidney Transplant Recipients with COVID-19 during Wave 1 versus Wave 2 at a Tertiary Care Center, India.印度一家三级医疗中心中，新冠疫情第一波与第二波期间肾移植受者的临床表现及预后综合比较
Int J Nephrol. 2022 Jun 2;2022:9088393. doi: 10.1155/2022/9088393. eCollection 2022.
8
Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection.新冠病毒感染后血液透析患者的死亡预测因素
J Clin Med. 2022 Jan 6;11(2):285. doi: 10.3390/jcm11020285.
9
Clinical Profile and Outcome of Haemodialysis in Patients With COVID-19 - A Single Centre Experience.2019冠状病毒病患者血液透析的临床特征与预后——单中心经验
Cureus. 2021 Aug 14;13(8):e17170. doi: 10.7759/cureus.17170. eCollection 2021 Aug.
10
Riding the COVID-19 Tsunami in India: A nephrologist's perspective.亲历印度的新冠疫情海啸：一位肾病学家的视角
Kidney Int Rep. 2021 Aug;6(8):2011-2013. doi: 10.1016/j.ekir.2021.06.018. Epub 2021 Jun 26.
本文引用的文献
1
The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action.为透析患者接种严重急性呼吸综合征冠状病毒2疫苗的迫切需求：行动呼吁
Kidney Int. 2021 Apr;99(4):791-793. doi: 10.1016/j.kint.2021.02.003. Epub 2021 Feb 12.
2
COVID-19 in dialysis patients: outlasting and outsmarting a pandemic.透析患者中的 COVID-19：持续存在并超越大流行。
Kidney Int. 2020 Dec;98(6):1402-1404. doi: 10.1016/j.kint.2020.10.005. Epub 2020 Oct 13.
3
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.欧洲透析患者和肾移植受者的 ERA-EDTA 注册中心研究结果表明，他们因 COVID-19 导致的死亡率很高。
Kidney Int. 2020 Dec;98(6):1540-1548. doi: 10.1016/j.kint.2020.09.006. Epub 2020 Oct 15.
4
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients.法国透析患者全国队列中的 SARS-CoV-2 发病率低、死亡风险因素和疾病过程。
Kidney Int. 2020 Dec;98(6):1519-1529. doi: 10.1016/j.kint.2020.07.042. Epub 2020 Aug 25.
5
The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India.新冠疫情对印度肾病患者护理的不利影响。
Kidney Int Rep. 2020 Sep;5(9):1545-1550. doi: 10.1016/j.ekir.2020.06.034. Epub 2020 Jul 6.
6
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.伴有 COVID-19 的终末期肾病患者的住院结果。
Kidney Int. 2020 Dec;98(6):1530-1539. doi: 10.1016/j.kint.2020.07.030. Epub 2020 Aug 15.
7
Impact of COVID-19 on maintenance haemodialysis patients: The Indian scenario.COVID-19 对维持性血液透析患者的影响：印度现状。
Nephrology (Carlton). 2020 Dec;25(12):929-932. doi: 10.1111/nep.13760. Epub 2020 Aug 12.
8
Adding insult to injury: kidney replacement therapy during COVID-19 in India.雪上加霜：印度新冠疫情期间的肾脏替代治疗
Kidney Int. 2020 Jul;98(1):238-239. doi: 10.1016/j.kint.2020.04.019. Epub 2020 Apr 25.
9
The state of nephrology in South Asia.南亚的肾脏病学状况。
Kidney Int. 2019 Jan;95(1):31-37. doi: 10.1016/j.kint.2018.09.001. Epub 2018 Oct 26.
Zotero 插件